A new discovery in our feline friends may be the key to resolving drug resistance issues for many living with HIV.
The FDA has approved a years-in-development treatment for multidrug-resistant HIV, a boon for those who've become resistant to most or all available HIV meds.
The Conference on Retroviruses and Opportunistic Infections (CROI), “the world’s preeminent scientific conference on HIV and related conditions,” takes place March 4-7 at the Hynes Convention Center in Boston, Massachusetts.
Across the country, states desperate to prevent opioid addiction are considering medical cannabis as a solution.
The secret lies in a specific-type human leukocyte antigen (HLA) gene that helps infected cells evade the body’s first line of defense against HIV.
The founding chairman of the American Foundation for AIDS Research (amfAR) has died at 91.
The new development suppresses the virus in humanized mice, and has long-lasting potential for humans.